Most Active Stories
- New Analysis And Science Answer Governor Cuomo’s Fracking Concerns
- Anchor Stores Announced For Newburgh Shopping Complex
- BMC Nurses Picket Claiming Unsafe Staffing Levels
- Vermont GMO Supporters Decry Federal Bill Targeting State Level Legislation
- Conservation Group Praises USCG, EPA Oil-Spill Response Plan Effort
New York News
Sun June 16, 2013
Researchers Analyze Drug Campaigns’ Efforts to Sell Disease
Dartmouth Institute researchers Doctors Lisa Schwartz and Steven Woloshin have published a paper in the Journal of the American Medical Association (JAMA) analyzing how the Low Testosterone advertisements so prevalent on television are a perfect template for how drug companies manufacture and sell disease. WAMC’s North Country Bureau Chief Pat Bradley spoke recently with “Low T: How to Sell Disease” co-author Steven Woloshin.
The ads are all over television and the internet.
This ad from isitlowt-dot-com is a perfect example, according to two Dartmouth Institute for Health Policy & Clinical Practice researchers, of how drug companies are creating “disease awareness” campaigns. “Low T: How to Sell Disease” co-author Steven Woloshin says obstensibly the ads are an effort to teach people and medical professionals about a problem and potential treatment.
The Dartmouth Institute and the authors of “Low T How to Sell Disease” will host an international conference at Dartmouth in September on preventing overdiagnosis.